Quantbot Technologies LP Assembly Biosciences, Inc. Transaction History

Quantbot Technologies LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$3.14 - $3.9 $64,391 - $79,977	-20,507 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$3.8 - $4.56 $77,926 - $93,511	20,507 New	20,507 $79,000
Q1 2021 May 14, 2021	SELL	$4.33 - $6.63 $19,918 - $30,498	-4,600 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$4.87 - $17.29 $22,402 - $79,534	4,600 New	4,600 $27,000
Q3 2019 Nov 12, 2019	SELL	$9.83 - $14.82 $16,711 - $25,194	-1,700 Closed	0 $0

Q2 2019 Aug 13, 2019	BUY	$12.9 - $20.8 $21,930 - $35,360	1,700 New	1,700 $22,000
Q3 2018 Nov 13, 2018	SELL	$34.41 - $44.23 $22,607 - $29,059	-657 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$39.21 - $50.29 $97,711 - $125,322	-2,492 Reduced 79.14%	657 $25,000
Q1 2018 May 11, 2018	BUY	$41.7 - $64.16 $131,313 - $202,039	3,149 New	3,149 $154,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $647M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.